Malaspina, P
If there are no GI symptoms but the drug was not DCd as suggested, treat as full stomach, evaluate contents with ultrasound, and consider delaying the procedure
Due to limited clinical data, the full safety profile, potential adverse effects, dosage standards, and long-term implications remain under investigation
How does BPC-157 compare to other peptides regarding pregnancy safety? BPC-157 and most research peptides (TB-500, thymosin beta-4 derivatives, growth hormone secretagogues) lack human pregnancy safety data and occupy identical regulatory categories as investigational compounds
The reported methods below were modified based on the standard procedures provided by Novogene
The most recent comprehensive synthesis is a July 2025 systematic review in the HSS Journal , the musculoskeletal journal of the Hospital for Special Surgery in New York, led by Nikhil Vasireddi at Case Western Reserve University School of Medicine